My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

52.50 -0.51 (-0.96%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lantheus Holdings, Inc. - Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Lantheus Holdings, Inc (LNTH) Q3 2021 Earnings Call Transcript ↗

November 07, 2021

LNTH earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal ↗

July 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...

Via Benzinga

Why Lantheus Holdings' Stock Is Trading Higher Today ↗

May 27, 2021

Lantheus Holdings (NASDAQ:LNTH) shares are trading higher ...

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

Return on Capital Employed Overview: Lantheus Holdings ↗

August 04, 2021

After pulling data from Benzinga Pro it seems like during Q2, Lantheus Holdings (NASDAQ:LNTH) brought in sales totaling $101.06 million. However, earnings decreased 7559.89%,...

Via Benzinga

Lantheus Announces the First and Only FDA Cleared AI-Enabled PSMA Digital Application, aPROMISE™, Strengthening Lantheus’ Leadership in Prostate Cancer

July 29, 2021

From Lantheus Holdings, Inc.

Via Business Wire

Lantheus Holdings, inc (LNTH) Q2 2021 Earnings Call Transcript ↗

July 28, 2021

LNTH earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Lantheus Stock Gains As Q2 Earnings Surpasses Expectations; Raises FY2021 Outlook ↗

July 28, 2021

Lantheus Holdings Inc (NASDAQ: LNTH) clocked $101.1 million in sales for Q2 of 2021, beating the consensus of $94.9 million, representing an increase of 53.1% Y/Y. Sales...

Via Benzinga

Lantheus Holdings: Q2 Earnings Insights ↗

July 28, 2021

Shares of Lantheus Holdings (NASDAQ:LNTH) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share increased 10.00% over the past...

Via Benzinga

Lantheus Holdings, Inc. Reports Second Quarter 2021 Financial Results

July 28, 2021

From Lantheus Holdings, Inc.

Via Business Wire

Earnings Preview: Lantheus Holdings ↗

July 27, 2021

On Wednesday, July 28, Lantheus Holdings (NASDAQ:LNTH) will release its latest earnings report. Decipher the announcement with Benzinga's help. Net Income, Earnings, And Earnings...

Via Benzinga

Lantheus Holdings to Host Second Quarter 2021 Earnings Conference Call and Webcast on July 28, 2021 at 8:00 a.m. Eastern Time

July 14, 2021

From Lantheus Holdings, Inc.

Via Business Wire

The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures ↗

July 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 1) Alexion Pharmaceuticals, Inc...

Via Benzinga

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More ↗

July 25, 2021

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...

Via Benzinga

Lantheus To Present Piflufolastat F 18 Data at the Virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2021 Annual Meeting

June 14, 2021

From Lantheus Holdings, Inc.

Via Business Wire

The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs ↗

June 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune's Readout ↗

June 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 2) BioCryst Pharmaceuticals,...

Via Benzinga

Stocks That Hit 52-Week Highs On Tuesday ↗

June 29, 2021

Tuesday's morning session saw 105 companies set new 52-week highs. Things to Consider: The largest company by market cap to break to a new 52-week high was...

Via Benzinga

The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs ↗

June 25, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24) AngioDynamics, Inc. (NASDAQ...

Via Benzinga

The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements ↗

June 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 1) Anika Therapeutics, Inc. (...

Via Benzinga

The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO ↗

June 24, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates ↗

June 01, 2021

The FDA review machinery worked overtime in May, completing reviews of several drug applications. Except for stray rejections or delays, the agency churned out mostly positive...

Via Benzinga

60 Biggest Movers From Yesterday ↗

May 28, 2021

Gainers Vertex Energy, Inc. (NASDAQ: VTNR) shares climbed 124.2% to settle at $3.99 on Thursday after the company announced plans to acquire a Alabama refinery and related...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 27, 2021

Gainers Rezolute (NASDAQ:RZLT) shares rose 46.68% to $11.28 during Thursday's regular session. As of 12:30 EST, Rezolute's stock is trading at a volume of 1.4...

Via Benzinga

41 Stocks Moving In Thursday's Mid-Day Session ↗

May 27, 2021

Gainers 1847 Goedeker Inc. (NYSE: GOED) shares jumped 156.5% to $11.08 after dropping over 8% on Wednesday. Vertex Energy, Inc. (NASDAQ: VTNR) jumped 117% to $3.8604 after the...

Via Benzinga

Why Lantheus Stock Is Soaring Today ↗

May 27, 2021

Investors are cheering FDA approval for the company's prostate cancer imaging agent.

Via The Motley Fool

Lantheus Shares Trading Higher On FDA Approval For Imaging Agent For Identification Of Prostate Cancer ↗

May 27, 2021

The FDA has approved Lantheus Holdings Inc's (NASDAQ: LNTH) Pylarify, a positron emission tomography (PET) imaging agent, to identify suspected metastasis...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 27, 2021

Gainers Zosano Pharma (NASDAQ:ZSAN) stock moved upwards by 22.59% to $0.91 during Thursday's pre-market session. The company's market cap stands at $97.3 million....

Via Benzinga

The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs ↗

May 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26) I-Mab (NASDAQ: IMAB)...

Via Benzinga

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.